Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

BGNE

BeiGene (BGNE)

BeiGene Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BGNE
FechaHoraFuenteTítuloSímboloCompañía
17/09/202416:01AllPennyStocks.comTargeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer HopeNASDAQ:BGNEBeiGene Ltd
17/09/202406:00Business WireBeiGene Receives Israeli Ministry of Health Approval for TEVIMBRA® for the Treatment of Oesophageal Squamous Cell Carcinoma (OSCC) After Prior ChemotherapyNASDAQ:BGNEBeiGene Ltd
16/09/202407:00Business WireTislelizumab, inibidor PD-1 da BeiGene, é aprovado no Brasil para o tratamento de carcinoma espinocelular de esôfago (ESCC) e câncer de pulmão de células não pequenas (NSCLC)NASDAQ:BGNEBeiGene Ltd
10/09/202413:59Business WireBeiGene présente les données de TEVIMBRA® sur les cancers pulmonaires et gastro-intestinaux au Congrès de l’ESMO 2024NASDAQ:BGNEBeiGene Ltd
10/09/202413:59Business WireBeiGene präsentiert TEVIMBRA®-Daten bei Lungen- und Magen-Darm-Krebs auf dem ESMO 2024NASDAQ:BGNEBeiGene Ltd
09/09/202413:52Business WireBeiGene annonce la mise à jour de la formation de son équipe de direction commercialeNASDAQ:BGNEBeiGene Ltd
09/09/202413:51Business WireBeiGene gibt Wechsel im kommerziellen Führungsteam bekanntNASDAQ:BGNEBeiGene Ltd
09/09/202406:00Business WireBeiGene Announces Updates to Commercial Leadership TeamNASDAQ:BGNEBeiGene Ltd
09/09/202400:00Business WireBeiGene Highlights TEVIMBRA® Data in Lung and Gastrointestinal Cancers at ESMO 2024NASDAQ:BGNEBeiGene Ltd
29/08/202406:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGNEBeiGene Ltd
28/08/202405:01Business WireBeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:BGNEBeiGene Ltd
26/08/202405:00Business WireBeiGene’s BGB-16673 Receives U.S. FDA Fast Track Designation for CLL/SLLNASDAQ:BGNEBeiGene Ltd
08/08/202415:46Business Wireベイジーン、2024年第2四半期決算および事業に関する最新情報を発表し、グローバル成長の次なる段階へNASDAQ:BGNEBeiGene Ltd
08/08/202407:23Business WireBeiGene公布2024年第二季財務業績和公司最新情況,進入全球成長的新階段NASDAQ:BGNEBeiGene Ltd
08/08/202407:22Business WireBeiGene startet mit der Bekanntgabe der Finanzergebnisse des zweiten Quartals 2024 und Unternehmens-Updates in die nächste Phase seines globalen WachstumsNASDAQ:BGNEBeiGene Ltd
08/08/202407:22Business WireBeiGene entame la prochaine phase de sa croissance mondiale en annonçant ses résultats financiers du deuxième trimestre 2024 et des nouvelles de l’entrepriseNASDAQ:BGNEBeiGene Ltd
07/08/202406:32Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:BGNEBeiGene Ltd
07/08/202405:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BGNEBeiGene Ltd
07/08/202405:00Business WireBeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:BGNEBeiGene Ltd
30/07/202415:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BGNEBeiGene Ltd
23/07/202414:10Business Wireベイジーン、米国に生物製剤製造および臨床研究開発の旗艦施設を開設し、世界のより多くの患者に医薬品を届けるためのグローバルな拡大を継続NASDAQ:BGNEBeiGene Ltd
23/07/202414:10Business WireBeiGene設立美國旗艦生物製劑生產和臨床研發機構,繼續全球擴張,為全球更多病患提供藥品NASDAQ:BGNEBeiGene Ltd
23/07/202412:56Business WireBeiGene inaugure un site phare de fabrication de produits biologiques et de R&D clinique aux États-Unis. La société poursuit également son expansion mondiale afin de proposer des médicaments à un plus grand nombre de patients dans le monde entier.NASDAQ:BGNEBeiGene Ltd
23/07/202412:56Business WireBeiGene eröffnet Flaggschiff-Anlage für Biologika-Herstellung und klinische Forschung und Entwicklung in den USA und setzt die globale Expansion fort, um mehr Patienten auf der ganzen Welt mit Medikamenten zu versorgenNASDAQ:BGNEBeiGene Ltd
23/07/202406:00Business WireBeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the WorldNASDAQ:BGNEBeiGene Ltd
18/07/202411:32Business Wireベイジーン、アーロン・ローゼンバーグ氏を最高財務責任者に任命NASDAQ:BGNEBeiGene Ltd
18/07/202409:16Business WireBeiGene annonce la nomination d'Aaron Rosenberg au poste de Chief Financial OfficerNASDAQ:BGNEBeiGene Ltd
18/07/202408:28Business WireBeiGene宣布任命Aaron Rosenberg為財務長NASDAQ:BGNEBeiGene Ltd
18/07/202408:28Business WireBeiGene gibt die Ernennung von Aaron Rosenberg zum Finanzvorstand bekanntNASDAQ:BGNEBeiGene Ltd
18/07/202405:30Business WireBeiGene Announces Appointment of Aaron Rosenberg as Chief Financial OfficerNASDAQ:BGNEBeiGene Ltd
 Showing the most relevant articles for your search:NASDAQ:BGNE